HEPATOLOGY IN THE ERA OF MASLD: Fatty Liver Disease Diagnosis and Management.

★★★★★ 4.8 68 Bewertungen

€57.92
Preis bei Onlinekauf
Kostenloser Versand 30 Tage kostenlose Rückgabe

Verkauft und versendet von noticiasdelaquinta.com.ar
Wir bemühen uns, Ihnen genaue Produktinformationen anzuzeigen. Hersteller, Lieferanten und andere stellen die hier gezeigten Angaben bereit.
€57.92
Preis bei Onlinekauf
Kostenloser Versand 30 Tage kostenlose Rückgabe

Wie möchten Sie Ihren Artikel erhalten?
Die ersten 30 Tage sind kostenlos! Wählen Sie den Tarif an der Kasse.
Versand
Ankunft 05.10.
Kostenlos
Abholung
In der Nähe prüfen
Lieferung
Nicht verfügbar

Verkauft und versendet von noticiasdelaquinta.com.ar
30 Tage kostenlose Rückgabe Details

Produktdetails

Artikelnummer 233476567 Erscheinungsdatum 2026/06/27 Listenpreis €57.92 Modellnummer 233476567
Kategorie

A modern liver medicine reference should not feel outdated before it reaches your desk.Hepatology in the Era of MASLD gives clinicians, trainees, and advanced healthcare readers a structured guide to the new language, diagnostic pathways, risk stratification tools, and treatment landscape reshaping fatty liver care.Built around the transition from NAFLD and NASH to MASLD and MASH, this professional reference explains how metabolic dysfunction, steatotic liver changes, fibrosis risk, diabetes, cardiovascular disease, cirrhosis, hepatocellular carcinoma, lifestyle intervention, resmetirom, GLP-1 receptor agonists, and emerging therapies fit into contemporary practice. Rather than treating the topic as a narrow liver condition, it frames MASLD as a multisystem cardiometabolic problem that requires coordinated clinical reasoning. The book is especially useful for readers who need a clinically organized overview of a fast-changing field without losing depth, terminology accuracy, or therapeutic context.Inside, you will:Understand the MASLD, MASH, MetALD, and steatotic liver disease terminology now used across current clinical literature.Navigate laboratory, serum-based, and imaging-based approaches to fibrosis assessment and specialist referral.Connect insulin resistance, hepatic lipotoxicity, inflammation, and fibrogenesis to real clinical decision-making.Review complications including cirrhosis, portal hypertension, and hepatocellular carcinoma with a practical risk-focused lens.Compare lifestyle therapy, cardiometabolic intervention, resmetirom, incretin-based therapies, and emerging pharmacologic options.Apply a multidisciplinary perspective that links hepatology, endocrinology, internal medicine, primary care, and cardiovascular risk reduction.Designed for hepatology and gastroenterology fellows, internists, endocrinologists, primary care clinicians, advanced practice providers, and senior medical learners, this book offers a clear pathway through one of the most important updates in modern metabolic liver medicine. Its structure supports quick orientation, deeper study, and professional review across both diagnostic and therapeutic chapters.If you want a current, clinically grounded reference for understanding and explaining metabolic dysfunction-associated steatotic liver disease, this book is designed to help you study the field with clarity, structure, and professional confidence. Read more

ASIN B0H1LPPB3D
ISBN13 979-8196630262
Language English
Publisher Independently published
Dimensions 8.5 x 1.19 x 11 inches
Item Weight 3.27 pounds
Print length 527 pages
Publication date May 12, 2026

Korrektur der Produktinformationen

Wenn Sie Unvollständigkeiten oder Fehler in den Produktinformationen auf dieser Seite bemerken, nutzen Sie bitte das Korrekturformular unten.

Korrekturanfrage

Kundenbewertungen

4.8 von 5
★★★★★
68 Bewertungen | 28 Rezensionen
So wird die Artikelbewertung berechnet
Alle Bewertungen anzeigen
5 Sterne
87% (59)
4 Sterne
2% (1)
3 Sterne
1% (1)
2 Sterne
0% (0)
1 Stern
10% (7)
Sortieren nach

Für dieses Produkt liegen derzeit keine schriftlichen Bewertungen vor.